Polymorphisms in methotrexate pathways: what is clinically relevant, what is not, and what is promising.

Gervasini, Guillermo

Polymorphisms in methotrexate pathways: what is clinically relevant, what is not, and what is promising. [electronic resource] - Current drug metabolism Jul 2009 - 547-66 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1875-5453

10.2174/138920009789375414 doi


Humans
Immunosuppressive Agents--adverse effects
Methotrexate--adverse effects
Pharmacogenetics
Polymorphism, Genetic